Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | USP2 | O75604 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11039676 | 1.00 | ALDH1A1 (0.42) | ALDH1A1TSHRCYP2C19USP2 | |
| SCHEMBL226936 | 1.00 | ALDH1A1 (0.42) | ALDH1A1TSHRCYP2C19USP2 | |
| SCHEMBL4004633 | 1.00 | ALDH1A1 (0.42) | ALDH1A1TSHRCYP2C19USP2 | |
| SCHEMBL3708731 | 1.00 | ALDH1A1 (0.42) | ALDH1A1TSHRCYP2C19USP2 | |
| SCHEMBL3708709 | 1.00 | ALDH1A1 (0.42) | ALDH1A1TSHRCYP2C19USP2 | |
| SCHEMBL535863 | 1.00 | ALDH1A1 (0.42) | ALDH1A1TSHRCYP2C19USP2 | |
| SCHEMBL8732941 | 1.00 | ALDH1A1 (0.42) | ALDH1A1TSHRCYP2C19USP2 | |
| SCHEMBL11423768 | 1.00 | ALDH1A1 (0.42) | ALDH1A1TSHRCYP2C19USP2 | |
| SCHEMBL18249750 | 0.96 | ALDH1A1 (0.40) | ALDH1A1TSHRCYP2C19 | |
| SCHEMBL4612532 | 0.95 | ALDH1A1 (0.37) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7019175-B2 | Catalytic oxidation of alkane, particularly cycloalkanes, to ketones, alcohols and acids using a 1,1,2,3-tetraoxo-, a 1,1,2-trioxo,3-thioxo, a 1,1-dioxo,2-hydroxy-,3-oxo- or thioxo-isothiazole or analogous compound; activation of oxygen or air and promoting the oxidation at mild temperatures | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 2006-03-28 | — | — | US | disclosed |
| US-20050020861-A1 | Catalytic oxidatin process | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 2005-01-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050020861-A1 | Catalytic oxidatin process | AOC2, AOX1, NOX5 | ALDH1A1 486/4885TSHR 3212/4885CYP2C19 177/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.